Skip to main content
S 2254 118th Congress Senate Health Accounting and auditing Congressional oversight Contracts and agency Drug safety, medical device, and laboratory regulation Government information and archives Government studies and investigations Health care costs and insurance Prescription drugs Retail and wholesale trades

Medicare PBM Accountability Act

Introduced: July 12, 2023 Introduced by: Cortez Masto, Catherine Democratic · Nevada See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 12, 2023
Read twice and referred to the Committee on Finance.
Jul 12, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medicare PBM Accountability Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.

Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

What's happening now July 12, 2023

Read twice and referred to the Committee on Finance.

 Related & companion bills 2
  • S 2973 Related bill Modernizing and Ensuring PBM Accountability Act
  • HR 5385 Identical bill Medicare PBM Accountability Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 2

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 3
All 3 Democratic 1 Republican 2
R
Crapo, Mike
Idaho · Jul 12, 2023
 R
Tillis, Thomas
North Carolina · Jul 12, 2023
 D
Wyden, Ron
Oregon · Jul 12, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2254: Medicare PBM Accountability Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2254/
MLA
"S. 2254: Medicare PBM Accountability Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2254/.
Bluebook (legal)
S. 2254, 118th Cong. (2026), https://openamerica.io/bill/118-S-2254/.
Markdown link
[S. 2254: Medicare PBM Accountability Act](https://openamerica.io/bill/118-S-2254/)
Report a problem